News | January 01, 2023
Briefs: Kilitch Drugs India, Family Care Hospitals and Krishna Institute of Medical Sciences
Krishna Institute of Medical Sciences to consider raising Rs. 300 crores
Krishna Institute of Medical Sciences to consider raising Rs. 300 crores
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
The scheme is subject to statutory and regulatory approvals as may be necessary.
Ipca Laboratories now holds 58.88% of the paid-up equity share capital of the company.
Gates Frontier, Bezos Expeditions, Reliance Digital Health Limited, Greenoaks, Alumni Ventures, Moore Strategic Ventures, and Project X join ARCH as new additional investors
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
Company to open new headquarters in 2024
Subscribe To Our Newsletter & Stay Updated
